Identification of a large intra-exonic deletion in exon 18 in a pancreatic ductal adenocarcinoma

Identification of a large intra-exonic deletion in exon 18 in a pancreatic ductal adenocarcinoma

By 2030, pancreatic cancer will become the second leading cause of cancer-related deaths in the United States and in Europe. The management of patients with advanced pancreatic cancer relies on chemotherapy and poly (ADP-ribose) polymerase inhibitors for patients who carry BRCA1/2 inactivating alter...

Full description

Bibliographic Details
Main Authors: Inès Debbabi, Sophie Vacher, Cindy Neuzillet, Jérome Cros, Françoise Revillon, Ambre Petitalot, Anthony Turpin, Samantha Antonio, Elodie Girard, Célia Dupain, Maud Kamal, Pascal Hammel, Ivan Bièche, Julien Masliah-Planchon, Sandrine M. Caputo
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359221146132

Internet

https://doi.org/10.1177/17588359221146132

Similar Items